Neuropeptide agonist

This page covers all Neuropeptide agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Oxytocin receptor (OXTR), VIP receptor (VPAC1/VPAC2).

Targets

Oxytocin receptor (OXTR) · VIP receptor (VPAC1/VPAC2)

Marketed (2)

• Oxytocin (Low dose) · The University of Texas Medical Branch, Galveston · Psychiatry / Neurology
  Low-dose oxytocin binds to oxytocin receptors to modulate social bonding, trust, and prosocial behaviors, with potential therapeutic effects on social dysfunction and anxiety.
• VIP · Danish Headache Center · Neurology
  VIP (Vasoactive Intestinal Peptide) is a neuropeptide that acts as a vasodilator and neuromodulator to reduce migraine and headache symptoms.